Agnes Gouble

8 Rue De La Croix Jarry
Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.

Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.

Journal: Nature communications
Published: August 08, 2023

Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies.

Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies.

Journal: Cancer immunology research
Published: November 18, 2022

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing.

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing.

Journal: Nature communications
Published: November 30, 2020

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Journal: Nature communications
Published: July 22, 2020

Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.

Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.

Journal: Nature communications
Published: July 22, 2020

Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.

Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.

Journal: PloS one
Published: May 27, 2019

Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.

Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.

Journal: Leukemia & lymphoma
Published: August 11, 2017

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.

Journal: Blood
Published: August 19, 2015

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Journal: Stem cell reports
Published: February 06, 2015

Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.

Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.

Journal: Cancer research
Published: November 10, 2014

Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells.

Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells.

Journal: Molecular therapy. Methods & clinical development
Published: January 01, 2014

megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering.

megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering.

Journal: Nucleic acids research
Published: November 29, 2013
Showing 1-12 of 18

Last Updated: 09/26/2026